MAIA Biotechnology Inc.

AMEX: MAIA · Real-Time Price · USD
1.56
0.00 (0.00%)
At close: Aug 15, 2025, 10:09 AM

MAIA Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-16.96M -20.18M -16.18M -7.79M
Interest Income
318.37K 27.63K 1.87K 2.01K
Pretax Income
-23.34M -19.77M -16.08M -12.58M
Net Income
-23.25M -19.77M -15.81M -12.5M
Selling & General & Admin
6.95M 9.07M 6.14M 4.29M
Research & Development
10.01M 11.11M 8.62M 3.45M
Other Expenses
n/a n/a 1.1M n/a
Operating Expenses
16.96M 20.18M 15.86M 7.74M
Interest Expense
57.00 n/a 6.97K 827.54K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
16.96M 20.18M 16.18M 7.74M
Income Tax Expense
-79.95K n/a 36.69K n/a
Shares Outstanding (Basic)
22.2M 13.26M 9.28M 10.64M
Shares Outstanding (Diluted)
22.2M 13.26M 9.28M 10.64M
EPS (Basic)
-1.05 -1.49 -1.7 -1.18
EPS (Diluted)
-1.05 -1.49 -1.7 -1.18
EBITDA
-16.96M -20.18M -16.18M -7.74M
EBIT
-16.96M -20.18M -16.08M -11.75M
Depreciation & Amortization
n/a n/a n/a 7.79M